Company news
Sino Biological Inc. Class A (SZSE:301047) news
Sino Biological Inc. Class A news releases on 6ix. Latest, Aug 26, 2026: Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom…
Press releases & updates
Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays
August 26, 2026
Sino Biological's Cell-Free Protein Synthesis Supports Tencent AI for Life Sciences Lab's Protein Design Study Published in Nature Communications
May 28, 2026
Sino Biological Launches XPressMAX™ Cell-Free Protein Synthesis Kit, Accelerating AI-Powered High-Throughput Antibody Drug Discovery
May 19, 2026
Sino Biological Launches XPressMAX(TM) Cell-Free Protein Synthesis Kit, Accelerating AI-Powered High-Throughput Antibody Drug Discovery
May 18, 2026
Advancing Influenza Vaccine Development: Sino Biological Launches Antigens for the 2026-2027 Northern Hemisphere Influenza Vaccine Strains
March 2, 2026
Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development
January 28, 2026
Sino Biological Sets New Industry Standard With ProPure(TM) Endotoxin-Free Proteins Made in the USA
July 14, 2025
Sino Biological Issues Formal Statement Regarding Current Global Tariff Discussions
April 28, 2025
Sino Biological Finalizes the Acquisition of SignalChem Biotech, Strengthening Global Presence and Expanding Product Portfolio
April 26, 2024
Sino Biological Announces the Opening of Its New US-Based Center for Bioprocessing
October 9, 2023
Sino Biological Announces Construction of Its New US-Based Center for Bioprocessing
November 21, 2022
Sino Biological Invests Over 200M RMB to Establish New Subsidiaries in Taizhou and Suzhou, China
March 15, 2022